4504 ORAL A phase II study of continuous daily administration of sunitinib in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC) – final results

✍ Scribed by Escudier, B.; Srinivas, S.; Roigas, J.; Gillessen, S.; Harmenberg, U.; De Mulder, P.H.; Fountzilas, G.; Vogelzang, N.; Peschel, C.; Flodgren, P.

• Book ID: 122876915
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 78 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(07)71135-7